{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:04:55Z","timestamp":1780574695231,"version":"3.54.1"},"reference-count":380,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Analytical Chemistry"],"DOI":"10.1080\/10408347.2026.2667373","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:37:07Z","timestamp":1780573027000},"page":"1-47","source":"Crossref","is-referenced-by-count":0,"title":["State-of-the-Art Analytical Techniques for Quantifying DPP-4 Inhibitor Combinations: A Critical Review"],"prefix":"10.1080","author":[{"given":"Sakshi","family":"Hadawale","sequence":"first","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM\u2019s NMIMS, Deemed to be University","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambhavi","family":"Shahi","sequence":"additional","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM\u2019s NMIMS, Deemed to be University","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sharma","sequence":"additional","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM\u2019s NMIMS, Deemed to be University","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kanugo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Quality Assurance, SVKM Institute of Pharmacy","place":["Dhule, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"World Health Organization. Diabetes [Internet]. Geneva: WHO; 2023. [cited 2023 Oct 2]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"e_1_3_3_3_1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. Available from: https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03089.x"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.149"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198223060-00003"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998288292240409060854"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S1944"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00389"},{"key":"e_1_3_3_10_1","unstructured":"DrugBank. Sitagliptin: Uses interactions mechanism of action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB01261."},{"key":"e_1_3_3_11_1","unstructured":"DrugBank. Saxagliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB06335."},{"key":"e_1_3_3_12_1","unstructured":"DrugBank. Linagliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB08882."},{"key":"e_1_3_3_13_1","unstructured":"Vildagliptin: Uses Interactions Mechanism of Action. | DrugBank Online [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB04876."},{"key":"e_1_3_3_14_1","unstructured":"DrugBank. Alogliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB06203."},{"key":"e_1_3_3_15_1","unstructured":"DrugBank. Gemigliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB12412."},{"key":"e_1_3_3_16_1","unstructured":"DrugBank. Omarigliptin: Uses interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB11992."},{"key":"e_1_3_3_17_1","unstructured":"DrugBank. Anagliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB12417."},{"key":"e_1_3_3_18_1","unstructured":"DrugBank. Teneligliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB11950."},{"key":"e_1_3_3_19_1","unstructured":"DrugBank. Trelagliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB15323."},{"key":"e_1_3_3_20_1","unstructured":"DrugBank. Evogliptin: Uses Interactions Mechanism of Action [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/go.drugbank.com\/drugs\/DB12625."},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Xu S.; Tatosian D.; Mcintosh I.; Caceres M.; Matthews C.; Samuel K.; et al. Absorption Metabolism and Excretion of [14C]Omarigliptin a Once-Weekly DPP-4 Inhibitor in Humans. Xenobiotica 2018;48(6):584\u201391. DOI: 10.1080\/00498254.2017.1346333.","DOI":"10.1080\/00498254.2017.1346333"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Furuta S.; Smart C.; Hackett A.; Benning R.; Warrington S. Pharmacokinetics and Metabolism of [14C]anagliptin a Novel Dipeptidyl Peptidase-4 Inhibitor in Humans. Xenobiotica 2013;43(5):432\u201342. DOI: 10.3109\/00498254.2012.731618.","DOI":"10.3109\/00498254.2012.731618"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4721"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9664099"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S65678"},{"key":"e_1_3_3_26_1","first-page":"1392","article-title":"Sitagliptin and Metformin Hydrochloride in Pure and Tablet Dosage Form by UV\u2013Vis Spectroscopy","volume":"1","author":"Nyola N.","year":"2012","unstructured":"Nyola, N.; Govindasamy, J. Sitagliptin and Metformin Hydrochloride in Pure and Tablet Dosage Form by UV\u2013Vis Spectroscopy. World J. Pharm. Pharm. Sci. 2012, 1, 1392\u20131401.","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_27_1","first-page":"1011","article-title":"Development and Validation of Spectrophotometric Method for the Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Tablet Dosage Form","volume":"5","author":"Himabindu T.","year":"2016","unstructured":"Himabindu, T.; Narmadha, S.; Sireesha, D.; Vasudha, B. Development and Validation of Spectrophotometric Method for the Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Tablet Dosage Form. World J. Pharm. Res. 2016, 5, 1011\u20131018.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_28_1","article-title":"Development and Validation of Simultaneous Equation Method for the Estimation of Metformin and Sitagliptin by UV Spectroscopy","volume":"2","author":"Sujani P. V.","year":"2013","unstructured":"Sujani, P. V.; Phanindra, S. S.; Anasuya, P.; Reddy, Y. P.; Devanna, N. Development and Validation of Simultaneous Equation Method for the Estimation of Metformin and Sitagliptin by UV Spectroscopy. Res. Rev. J. Pharm. Pharm. Sci. 2013, 2.","journal-title":"Res. Rev. J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_29_1","first-page":"1","article-title":"Spectrophotometric Determination of Sitagliptin and Metformin in Their Pharmaceutical Formulation","volume":"3","author":"Rezk M.","year":"2012","unstructured":"Rezk, M. Spectrophotometric Determination of Sitagliptin and Metformin in Their Pharmaceutical Formulation. Int. J. Compr. Pharm. 2012, 3, 1\u20134.","journal-title":"Int. J. Compr. Pharm."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijcpr.2022v14i2.1963"},{"key":"e_1_3_3_31_1","first-page":"733","article-title":"Development and Validation of Spectrophotometric Method for Metformin and Sitagliptin by Absorbance Ratio Method","volume":"6","author":"Hinge M. A.","year":"2016","unstructured":"Hinge, M. A.; Patel, K. V. Development and Validation of Spectrophotometric Method for Metformin and Sitagliptin by Absorbance Ratio Method. J. Pharm. Sci. Biosci. Res. 2016, 6, 733\u2013739.","journal-title":"J. Pharm. Sci. Biosci. Res."},{"key":"e_1_3_3_32_1","article-title":"Simultaneous UV Spectrophotometric Method for Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Bulk and Tablet Dosage Form","volume":"4","author":"Mansuri S. L.","year":"2022","unstructured":"Mansuri, S. L.; Sonar, A. D. Simultaneous UV Spectrophotometric Method for Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Bulk and Tablet Dosage Form. Int. J. Multidiscip. Res. 2022, 4.","journal-title":"Int. J. Multidiscip. Res."},{"key":"e_1_3_3_33_1","article-title":"Development and Validation of Analytical Methods for Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Bulk and Tablets by Using UV Spectroscopy","volume":"2","author":"Kumar N. S.","year":"2012","unstructured":"Kumar, N. S.; Huidrom, S.; Anusha, N.; Prasad, V. V. L. N.; Diwan, P. V. Development and Validation of Analytical Methods for Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Bulk and Tablets by Using UV Spectroscopy. Int. J. Pharm. Ind. Res. 2012, 2.","journal-title":"Int. J. Pharm. Ind. Res."},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/139561"},{"key":"e_1_3_3_35_1","first-page":"13","article-title":"Development and Validation of RP-HPLC and HPTLC Methods for Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Bulk and Dosage Form","volume":"47","author":"Jadhav S. B.","year":"2013","unstructured":"Jadhav, S. B.; Kupkar, S. K.; Dharam, D. L.; Jangam, A. M.; Chaudhari, P. D. Development and Validation of RP-HPLC and HPTLC Methods for Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Bulk and Dosage Form. Ind. J. Pharm. Educ. Res. 2013, 47, 13\u201316.","journal-title":"Ind. J. Pharm. Educ. Res."},{"key":"e_1_3_3_36_1","first-page":"407","article-title":"A. Validated HPTLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk Drug and Formulation","volume":"5","author":"Raja T.","year":"2012","unstructured":"Raja, T.; Rao, L. A. Validated HPTLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk Drug and Formulation. Rasayan J. Chem. 2012, 5, 407\u2013413.","journal-title":"Rasayan J. Chem."},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-4150.2015.00076.0"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.4314\/epj.v31i1.6"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.5740\/jaoacint.11-383"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.9.10.4294-4302"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.4236\/ajac.2014.511082"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.33289\/IJRPC.09.7.2021.11(28)"},{"key":"e_1_3_3_43_1","first-page":"8","article-title":"RP-HPLC Method Development and Validation for Simultaneous Estimation of Metformin and Sitagliptin in Tablet Dosage Forms","volume":"3","author":"Sirisha G. R.","year":"2013","unstructured":"Sirisha, G. R.; Vasanth, P. M.; Ramesh, T.; Malothu, R. RP-HPLC Method Development and Validation for Simultaneous Estimation of Metformin and Sitagliptin in Tablet Dosage Forms. Int. J. Pharm. Res. Anal. 2013, 3, 8\u201312.","journal-title":"Int. J. Pharm. Res. Anal."},{"key":"e_1_3_3_44_1","first-page":"34","article-title":"Development and Validation of RP-HPLC Method for Determination of Metformin and Sitagliptin in Bulk and Pharmaceutical Dosage Form","volume":"5","author":"Sahoo S. K.","year":"2017","unstructured":"Sahoo, S. K.; Rao, V. R. P.; Ch, M. N. B. Development and Validation of RP-HPLC Method for Determination of Metformin and Sitagliptin in Bulk and Pharmaceutical Dosage Form. J. Appl. Pharm. Res. 2017, 5, 34\u201339.","journal-title":"J. Appl. Pharm. Res."},{"key":"e_1_3_3_45_1","article-title":"Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form Using RP-HPLC Method","volume":"5","author":"Sankar A. S. K.","year":"2015","unstructured":"Sankar, A. S. K.; Sythana, S.; Jhansi, A.; Shanmugasundaram, P.; Sumithra, M. Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form Using RP-HPLC Method. Int. J. Pharm. Tech. Res. 2015, 5.","journal-title":"Int. J. Pharm. Tech. Res."},{"key":"e_1_3_3_46_1","article-title":"Development and Validation of RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate from Bulk and Combined Dosage Form","volume":"3","author":"Shirode A. R.","year":"2014","unstructured":"Shirode, A. R.; Deodhar, M. S.; Maduskar, P. D.; Kadam, V. J. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate from Bulk and Combined Dosage Form. Int. J. Pharm. Res. Scholar. 2014, 3.","journal-title":"Int. J. Pharm. Res. Scholar."},{"key":"e_1_3_3_47_1","first-page":"696","article-title":"A. Validated RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk Drug and Pharmaceutical Formulation","volume":"2","author":"Raja T.","year":"2012","unstructured":"Raja, T.; Rao, L. A. Validated RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk Drug and Pharmaceutical Formulation. Int. J. Pharm. Chem. Biol. Sci. 2012, 2, 696\u2013702.","journal-title":"Int. J. Pharm. Chem. Biol. Sci."},{"key":"e_1_3_3_48_1","article-title":"Validated RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk Drug and Pharmaceutical Dosage Form","author":"Gangrade D. M.","year":"2015","unstructured":"Gangrade, D. M.; Sharma, A. K. Validated RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk Drug and Pharmaceutical Dosage Form. Der. Pharm. Lett. 2015.","journal-title":"Der. Pharm. Lett."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.20902\/IJCTR.2018.111149"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.33289\/IJRPC.09.7.2021.11(28)"},{"key":"e_1_3_3_51_1","first-page":"24","article-title":"Simultaneous Estimation of Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride in Bulk and Pharmaceutical Formulation by RP-HPLC","volume":"3","author":"Govindasamy J.","year":"2012","unstructured":"Govindasamy, J.; Nyola, N. Simultaneous Estimation of Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride in Bulk and Pharmaceutical Formulation by RP-HPLC. Int. J. Res. Pharm. Biomed. Sci. 2012, 3, 24\u201328.","journal-title":"Int. J. Res. Pharm. Biomed. Sci."},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.21474\/IJAR01\/15045"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijpi.2020.4.89"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.4172\/1948-593X.S1.014"},{"key":"e_1_3_3_55_1","first-page":"15","article-title":"Validation of a Rapid and Economical RP-HPLC Method for Simultaneous Determination of Metformin Hydrochloride and Sitagliptin Phosphate Monohydrate: Greenness Evaluation Using AGREE Score","volume":"35","author":"Raza A.","year":"2022","unstructured":"Raza, A.; Murtaza, S. H.; Hanif, S.; Iqbal, J.; Ali, I.; Aftab, T.; Shakir, R.; Bedar, R.; Syed, M. A. Validation of a Rapid and Economical RP-HPLC Method for Simultaneous Determination of Metformin Hydrochloride and Sitagliptin Phosphate Monohydrate: Greenness Evaluation Using AGREE Score. Pak. J. Pharm. Sci. 2022, 35, 15\u201321.","journal-title":"Pak. J. Pharm. Sci."},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.7439\/ijapa.v7i2.4375"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.32553\/ijmbs.v3i7.406"},{"key":"e_1_3_3_58_1","first-page":"37","article-title":"Development of a Simple, Rapid and Specific RP-HPLC Method for the Estimation of Metformin and Sitagliptin in Bulk and Combined Pharmaceutical Dosage Forms","volume":"7","author":"Mallepelli S.","year":"2017","unstructured":"Mallepelli, S.; Rao, N.; Nune, S. Development of a Simple, Rapid and Specific RP-HPLC Method for the Estimation of Metformin and Sitagliptin in Bulk and Combined Pharmaceutical Dosage Forms. Int. J. Pharm. Biol. Sci. 2017, 7, 37\u201345.","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.5155\/eurjchem.4.4.360-365.843"},{"key":"e_1_3_3_60_1","first-page":"47","article-title":"Development of Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate Monohydrate in Bulk as Well as in Pharmaceutical Formulation","volume":"4","author":"Kumar S. A.","year":"2013","unstructured":"Kumar, S. A.; Debnath, M.; Rao, J. V. L. S. Development of Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate Monohydrate in Bulk as Well as in Pharmaceutical Formulation. Der Pharmacia Sinica. 2013, 4, 47\u201361.","journal-title":"Der Pharmacia Sinica."},{"key":"e_1_3_3_61_1","first-page":"168","article-title":"Method Development and Validation of Sitagliptin and Metformin Using Reverse-Phase HPLC Method in Bulk and Tablet Dosage Form","volume":"5","author":"Karimulla S. K.","year":"2013","unstructured":"Karimulla, S. K.; Vasanth, P. M.; Ramesh, T.; Ramesh, M. Method Development and Validation of Sitagliptin and Metformin Using Reverse-Phase HPLC Method in Bulk and Tablet Dosage Form. Der. Pharm. Lett. 2013, 5, 168\u2013174.","journal-title":"Der. Pharm. Lett."},{"key":"e_1_3_3_62_1","doi-asserted-by":"crossref","unstructured":"Ahmad Khan K Gulab H Haider F. Method Development for the Determination of Commercial Formulation of Difenoconazole Fungicide Using UV-Visible Spectrophotometer. 2019.","DOI":"10.4172\/2155-9872.1000410"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijpps.2019v11i6.22699"},{"key":"e_1_3_3_64_1","first-page":"646","article-title":"Simultaneous Estimation of Metformin HCl and Sitagliptin Phosphate in Tablet Dosage Forms by RP-HPLC","volume":"4","author":"Pulla R. P.","year":"2011","unstructured":"Pulla, R. P.; Sastry, B. S.; Prasad, Y. R.; Raju, N. A. Simultaneous Estimation of Metformin HCl and Sitagliptin Phosphate in Tablet Dosage Forms by RP-HPLC. Res. J. Pharm. Technol. 2011, 4, 646\u2013649.","journal-title":"Res. J. Pharm. Technol."},{"key":"e_1_3_3_65_1","article-title":"Simultaneous Estimation of Metformin HCl and Sitagliptin in Drug Substance and Drug Products by RP-HPLC Method","volume":"8","author":"Aruna B.","year":"2017","unstructured":"Aruna, B.; Kumar, B. S.; Parthiban, P. Simultaneous Estimation of Metformin HCl and Sitagliptin in Drug Substance and Drug Products by RP-HPLC Method. Int. J. Chem. Pharm. Sci. 2017, 8.","journal-title":"Int. J. Chem. Pharm. Sci."},{"key":"e_1_3_3_66_1","doi-asserted-by":"crossref","unstructured":"Vani R.; Mohan G.; Jo D. Analytical Method Development and Validation for the Determination of Sitagliptin and Metformin Using Reverse-Phase HPLC Method in Bulk and Tablet Dosage Form. 2014.","DOI":"10.5958\/0974-360X.2015.00038.4"},{"key":"e_1_3_3_67_1","first-page":"649","article-title":"Stability-Indicating RP-HPLC Method and Its Validation for Analysis of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk and Pharmaceutical Dosage Form","volume":"4","author":"Rao N. S.","year":"2015","unstructured":"Rao, N. S.; Venkataramana, K.; Anitha, P. Stability-Indicating RP-HPLC Method and Its Validation for Analysis of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk and Pharmaceutical Dosage Form. World J. Pharm. Res. 2015, 4, 649\u2013662.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_68_1","first-page":"1339","article-title":"Analytical Method Development and Validation of RP-HPLC Method for Simultaneous Estimation of Metformin and Sitagliptin","volume":"4","author":"Padmalatha H.","year":"2015","unstructured":"Padmalatha, H.; Harish, M. Analytical Method Development and Validation of RP-HPLC Method for Simultaneous Estimation of Metformin and Sitagliptin. World J. Pharm. Pharm. Sci. 2015, 4, 1339\u20131369.","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_69_1","first-page":"1691","article-title":"Development and Validation of New Analytical Method for the Simultaneous Estimation of Metformin and Sitagliptin in Bulk and Dosage Form by RP-HPLC","volume":"6","author":"Kumar P. V.","year":"2017","unstructured":"Kumar, P. V.; Kavitha, M.; Patro, S.; Bhavya, C.; Bag, A. K. Development and Validation of New Analytical Method for the Simultaneous Estimation of Metformin and Sitagliptin in Bulk and Dosage Form by RP-HPLC. World J. Pharm. Res. 2017, 6, 1691\u20131700.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.1110-13"},{"key":"e_1_3_3_71_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.59566\/IJBS.2015.11190","article-title":"Improved Chromatographic Separation of Sitagliptin Phosphate and Metformin Hydrochloride","volume":"11","author":"Hendy M. S.","year":"2015","unstructured":"Hendy, M. S. Improved Chromatographic Separation of Sitagliptin Phosphate and Metformin Hydrochloride. Int. J. Biomed. Sci. 2015, 11, 190\u2013194.","journal-title":"Int. J. Biomed. Sci."},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmv055"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/22297928.2018.1479305"},{"key":"e_1_3_3_74_1","first-page":"463","article-title":"A Simple and Sensitive Method for Determination of Metformin and Sitagliptin in Human Plasma Using Liquid Chromatography and Tandem Mass Spectrometry","volume":"5","author":"Bonde S. L.","year":"2013","unstructured":"Bonde, S. L.; Bhadane, R. P.; Gaikwad, A.; Katale, D.; Gavali, S.; Narendran, A. S. A Simple and Sensitive Method for Determination of Metformin and Sitagliptin in Human Plasma Using Liquid Chromatography and Tandem Mass Spectrometry. Int. J. Pharm. Pharm. Sci. 2013, 5, 463\u2013470.","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2022v14i6.45140"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412914666181011141714"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.07.002"},{"key":"e_1_3_3_78_1","article-title":"New UV Spectrophotometric Method Development and Validation for the Estimation of Sitagliptin and Glimepiride in Pharmaceutical Dosage Forms and Bulk Drug","volume":"7","author":"Kumar D.","year":"2022","unstructured":"Kumar, D.; Khushboo, K.; Ashu, A.; Rao, T. S.; Sreedhar, C. New UV Spectrophotometric Method Development and Validation for the Estimation of Sitagliptin and Glimepiride in Pharmaceutical Dosage Forms and Bulk Drug. Int. J. Res. Trend. Innov. 2022, 7.","journal-title":"Int. J. Res. Trend. Innov."},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2023.123677"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kijoms.2015.06.002"},{"key":"e_1_3_3_81_1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00228-011-1177-2","article-title":"Pharmacokinetic Drug Interaction between Gemfibrozil and Sitagliptin in Healthy Indian Male Volunteers","volume":"68","author":"Arun K. P.","year":"2012","unstructured":"Arun, K. P.; Meda, V. S.; R.; Kucherlapati, V. S. P.; Dubala, A.; Deepalakshmi; et al. Pharmacokinetic Drug Interaction between Gemfibrozil and Sitagliptin in Healthy Indian Male Volunteers. Eur. J. Clin. Pharmacol. 2012, 68, 709\u2013714.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-023-02905-1"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5RA11448A"},{"key":"e_1_3_3_84_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.53879\/id.50.04.p0046","article-title":"Novel uv Spectrophotometric Method for Estimation of Sitagliptin Phosphate and Simvastatin by Area under Curve Method","volume":"50","author":"Chopde V. V.","year":"2013","unstructured":"Chopde, V. V.; Patil, P. M.; Rathod, S. D.; Chaudhari, P. D. Novel uv Spectrophotometric Method for Estimation of Sitagliptin Phosphate and Simvastatin by Area under Curve Method. Ind. Drug. 2013, 50, 46\u201352.","journal-title":"Ind. Drug."},{"key":"e_1_3_3_85_1","first-page":"292","article-title":"Development and Validation of HPTLC Method for the Estimation of Sitagliptin Phosphate and Simvastatin in Bulk and Marketed Formulation","volume":"4","author":"Rathod S.","year":"2012","unstructured":"Rathod, S.; Patil, P.; Chopade, V. Development and Validation of HPTLC Method for the Estimation of Sitagliptin Phosphate and Simvastatin in Bulk and Marketed Formulation. Int. J. Drug Dev. Res. 2012, 4, 292\u2013297.","journal-title":"Int. J. Drug Dev. Res."},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.143080"},{"key":"e_1_3_3_87_1","article-title":"Development and Validation of RP-HPLC Method for the Estimation of Sitagliptin Phosphate and Simvastatin in Bulk and Pharmaceutical Dosage Form","volume":"5","author":"Patil P. M.","year":"2015","unstructured":"Patil, P. M.; Rathod, S. D.; Chopade, V. V. Development and Validation of RP-HPLC Method for the Estimation of Sitagliptin Phosphate and Simvastatin in Bulk and Pharmaceutical Dosage Form. Int. J. Pharm. Pharm. Res. 2015, 5.","journal-title":"Int. J. Pharm. Pharm. Res."},{"key":"e_1_3_3_88_1","unstructured":"Chavhan V.; Ghante M.; Sawant S. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Sitagliptin Phosphate and Simvastatin in Bulk and Tablet Dosage Form. 2014."},{"key":"e_1_3_3_89_1","first-page":"34","article-title":"Novel RP-HPLC Method for Simultaneous Determination of Sitagliptin and Simvastatin in Bulk and Tablet Dosage Form","volume":"5","author":"Ravisankar P.","year":"2015","unstructured":"Ravisankar, P.; Hassaini, S. K.; Neha, S. M. Novel RP-HPLC Method for Simultaneous Determination of Sitagliptin and Simvastatin in Bulk and Tablet Dosage Form. IOSR J. Pharm. 2015, 5, 34\u201340.","journal-title":"IOSR J. Pharm."},{"key":"e_1_3_3_90_1","first-page":"1993","article-title":"Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Simvastatin and Sitagliptin in Tablet Dosage Form","volume":"4","author":"Patel T.","year":"2014","unstructured":"Patel, T.; Patel, T.; Suhagia, B. Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Simvastatin and Sitagliptin in Tablet Dosage Form. Ind. Am. J. Pharm. Res. 2014, 4, 1993\u20131999.","journal-title":"Ind. Am. J. Pharm. Res."},{"key":"e_1_3_3_91_1","first-page":"1611","article-title":"Validated RP-HPLC Method for the Simultaneous Estimation of Sitagliptin and Simvastatin in Dosage Forms","volume":"3","author":"Vodikala A.","year":"2012","unstructured":"Vodikala, A.; Vanka, A.; Simhadri, S. V.; Atla, S. R., Tata, S. Validated RP-HPLC Method for the Simultaneous Estimation of Sitagliptin and Simvastatin in Dosage Forms. Int. J. Chem. Anal. Sci. 2012, 3, 1611\u20131614.","journal-title":"Int. J. Chem. Anal. Sci"},{"key":"e_1_3_3_92_1","first-page":"265","article-title":"Validated RP-HPLC Method for the Estimation of Simvastatin and Sitagliptin","volume":"3","author":"Pv S.","year":"2014","unstructured":"Pv, S.; Reddy, P.; Devanna, N.; Phanindra, S. S. Validated RP-HPLC Method for the Estimation of Simvastatin and Sitagliptin. Schol. Acad. J. Pharm. 2014, 3, 265\u2013270.","journal-title":"Schol. Acad. J. Pharm."},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5659.2016.00026.6"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5675.2016.00011.9"},{"key":"e_1_3_3_95_1","first-page":"880","article-title":"A New, Simple, Sensitive, Accurate and Rapid Analytical Method Development and Validation for Simultaneous Estimation of Sitagliptin and Simvastatin in Tablet Dosage Form Using UPLC","volume":"6","author":"Reddy G. S. K.","year":"2014","unstructured":"Reddy, G. S. K.; Kumar, S. A.; Kumar, V. R. A New, Simple, Sensitive, Accurate and Rapid Analytical Method Development and Validation for Simultaneous Estimation of Sitagliptin and Simvastatin in Tablet Dosage Form Using UPLC. Int. J. PharmTech. Res. 2014, 6, 880\u2013893.","journal-title":"Int. J. PharmTech. Res."},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.2751"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2014.11.003"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijpca.2022.005"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041246"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.22270\/jmpas.v10i3.1169"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2022.120614"},{"key":"e_1_3_3_102_1","first-page":"1743","article-title":"RP-HPLC Method Development and Validation for Estimation of Dapagliflozin Propanediol Monohydrate and Sitagliptin from Synthetic Mixture","volume":"10","author":"Jay T.","year":"2015","unstructured":"Jay, T.; Tiwari, N.; Patani, P. RP-HPLC Method Development and Validation for Estimation of Dapagliflozin Propanediol Monohydrate and Sitagliptin from Synthetic Mixture. World J. Pharm. Pharm. Sci. 2015, 10, 1743\u20131757.","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_103_1","first-page":"d639","article-title":"Stability-Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate and Teneligliptin in Tablet Dosage Form","volume":"11","author":"Patel A. P.","year":"2023","unstructured":"Patel, A. P.; Patel, B. R.; Raval, U. A.; Patel, R. N.; Patel, J. G. Stability-Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate and Teneligliptin in Tablet Dosage Form. Int. J. Creat. Res. Thought. 2023, 11, d639\u2013d649.","journal-title":"Int. J. Creat. Res. Thought."},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-019-01959-4"},{"key":"e_1_3_3_105_1","unstructured":"Ms K.; Reddy M. Method Development and Validation of Ertugliflozin and Sitagliptin by Using Simultaneous Equation Method. 2019 9."},{"key":"e_1_3_3_106_1","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.13005\/ojc\/340543","article-title":"Novel Stress Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and Its Formulation","volume":"34","author":"Babu D. C.","year":"2018","unstructured":"Babu, D. C.; Chetty, C. M.; Mastanamma, S. K. Novel Stress Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and Its Formulation. Orient. J. Chem. 2018, 34, 2554\u20132561.","journal-title":"Orient. J. Chem."},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.54037\/WJPS.2021.91102"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.54037\/WJPS.2021.91210"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.54037\/WJPS.2022.100105"},{"key":"e_1_3_3_110_1","first-page":"59","article-title":"Chromatographic Study of Sitagliptin and Ertugliflozin under Quality-by-Design Paradigm","author":"Gurrala S.","year":"2023","unstructured":"Gurrala, S.; Anumolu, P. D.; Haripriya, D.; Subrahmanyam, C. V. S. Chromatographic Study of Sitagliptin and Ertugliflozin under Quality-by-Design Paradigm. Braz. J. Pharmaceut. Sci. 2023, 59.","journal-title":"Braz. J. Pharmaceut. Sci."},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5675.2020.00014.9"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.47750\/pnr.2022.13.S07.814"},{"key":"e_1_3_3_113_1","first-page":"261","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Ertugliflozin and Sitagliptin in Pharmaceutical Dosage Form by RP-HPLC","volume":"8","author":"Rani C.","year":"2021","unstructured":"Rani, C.; Pravalika, M. Analytical Method Development and Validation for Simultaneous Estimation of Ertugliflozin and Sitagliptin in Pharmaceutical Dosage Form by RP-HPLC. Eur. J. Biomed. Pharm. Sci. 2021, 8, 261\u2013267.","journal-title":"Eur. J. Biomed. Pharm. Sci."},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2022\/v34i20B35829"},{"key":"e_1_3_3_115_1","article-title":"RP-HPLC Method Development and Validation for Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and Tablet Dosage Forms","volume":"9","author":"Laxmi M.","year":"2019","unstructured":"Laxmi, M.; Kumari, R. V. V.; Marakatham, S.; Sathish Kumar, M. RP-HPLC Method Development and Validation for Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and Tablet Dosage Forms. Ind. J. Appl. Res. 2019, 9.","journal-title":"Ind. J. Appl. Res."},{"key":"e_1_3_3_116_1","article-title":"Stability-Indicating UPLC Method Development and Validation for Simultaneous Determination of Ertugliflozin and Sitagliptin","author":"Goud V. M.","year":"2019","unstructured":"Goud, V. M.; Prasanna, D. S.; Sirisha, P. B.; Sharma, J. V. C. Stability-Indicating UPLC Method Development and Validation for Simultaneous Determination of Ertugliflozin and Sitagliptin. Am. J. PharmTech. Res. 2019.","journal-title":"Am. J. PharmTech. Res."},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360X.2021.00844"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00231-5"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i30A31631"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412916999200630123120"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2018.12.016"},{"key":"e_1_3_3_122_1","first-page":"20","article-title":"New Analytical Method Development and Validation of Some Oral Hypoglycemic Drugs","volume":"3","author":"Sreedhar C.","year":"2012","unstructured":"Sreedhar, C.; Manogna, K.; Rao, T.; Akkamma, H. G.; Sukanya, K.; Shakir, V. K. New Analytical Method Development and Validation of Some Oral Hypoglycemic Drugs. Res. J. Pharm. Biol. Chem. Sci. 2012, 3, 20\u201330.","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"e_1_3_3_123_1","unstructured":"Kisan Gajul V.; Siddheshwar Tegeli V.; Thakkar N. M.; Patil S. A.; Kalshetti S. Development and Validation of Analytical Methods for Simultaneous Estimation of Sitagliptin Phosphate and Pioglitazone Hydrochloride. 2018."},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.4236\/ajac.2012.312112"},{"key":"e_1_3_3_125_1","first-page":"642","article-title":"Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Atorvastatin and Sitagliptin Phosphate in Synthetic Mixture","volume":"6","author":"Patel C. J.","year":"2019","unstructured":"Patel, C. J.; Patel, N. A.; Kirad, A. Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Atorvastatin and Sitagliptin Phosphate in Synthetic Mixture. Int. J. Pharm. Pharm. Res. 2019, 6, 642\u2013659.","journal-title":"Int. J. Pharm. Pharm. Res."},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoacint\/qsab171"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2018.v11i10.27083"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.46624\/ajptr.2020.v10.i6.007"},{"key":"e_1_3_3_129_1","first-page":"3267","article-title":"RP-HPLC Method for Simultaneous Determination of Metformin Hydrochloride, Rosiglitazone and Sitagliptin\u2014Application to Commercially Available Drug Products","volume":"3","author":"Inamdar H. P.","year":"2012","unstructured":"Inamdar, H. P.; Mhaske, A. A. RP-HPLC Method for Simultaneous Determination of Metformin Hydrochloride, Rosiglitazone and Sitagliptin\u2014Application to Commercially Available Drug Products. Int. J. Pharm. Sci. Res. 2012, 3, 3267\u20133276.","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"e_1_3_3_130_1","article-title":"Method Development and Validation of a Stability-Indicating Reversed-Phase Liquid Chromatographic Method for the Simultaneous Estimation of Metformin, Sitagliptin and Simvastatin in Presence of Their Degradation Products","volume":"144","author":"Kotecha N. C.","year":"2018","unstructured":"Kotecha, N. C.; Patel, J. K. Method Development and Validation of a Stability-Indicating Reversed-Phase Liquid Chromatographic Method for the Simultaneous Estimation of Metformin, Sitagliptin and Simvastatin in Presence of Their Degradation Products. Int. J. Pharm. Sci. Rev. Res. 2018, 144\u201353.","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"e_1_3_3_131_1","first-page":"630","article-title":"Simultaneous Estimation of Gliclazide and Sitagliptin Phosphate Monohydrate by Q-Analysis Method","volume":"7","author":"Reichal C. R.","year":"2015","unstructured":"Reichal, C. R.; Sangeetha, M.; Thirumoorthy, N. Simultaneous Estimation of Gliclazide and Sitagliptin Phosphate Monohydrate by Q-Analysis Method. J. Chem. Pharm. Res. 2015, 7, 630\u2013635.","journal-title":"J. Chem. Pharm. Res."},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.47760\/ijpsm.2022.v07i10.002"},{"key":"e_1_3_3_133_1","first-page":"5860","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Ipragliflozin and Sitagliptin in Tablet Form by RP-HPLC Method","volume":"9","author":"Nizami T.","year":"2018","unstructured":"Nizami, T. Analytical Method Development and Validation for Simultaneous Estimation of Ipragliflozin and Sitagliptin in Tablet Form by RP-HPLC Method. Intern. J. Pharm. Life Sci. 2018, 9, 5860\u20135865.","journal-title":"Intern. J. Pharm. Life Sci."},{"key":"e_1_3_3_134_1","unstructured":"El-Bagary R. I.; Elkady E. F.; Ayoub B. M. Spectrophotometric Methods for the Determination of Sitagliptin and Vildagliptin in Bulk and Dosage Forms. 2011."},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.5740\/jaoacint.17-0050"},{"key":"e_1_3_3_136_1","first-page":"495","article-title":"A Validated HPLC-PDA Method for Simultaneous Quantitation of Four Oral Antidiabetic Drugs and Application to Pharmaceutical Preparations","volume":"40","author":"AlShehri","year":"2018","unstructured":"AlShehri. A Validated HPLC-PDA Method for Simultaneous Quantitation of Four Oral Antidiabetic Drugs and Application to Pharmaceutical Preparations. J. Chem. Soc. Pak. 2018, 40, 495\u2013501.","journal-title":"J. Chem. Soc. Pak."},{"key":"e_1_3_3_137_1","unstructured":"Validated Liquid Chromatographic Method for Simultaneous Determination of Metformin Pioglitazone Sitagliptin Repaglinide Glibenclamide and Gliclazide\u2014Application for Counterfeit Drug Analysis. J. Anal. Bioanal. Tech. 2015."},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902019000217394"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412915666190708162012"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-011-4698-8"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i4-s.3828"},{"key":"e_1_3_3_142_1","first-page":"668","article-title":"Development and Validation of UV-Spectroscopic First Derivative and High-Performance Thin Layer Chromatography Analytical Methods for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate and Saxagliptin Hydrochloride in Synthetic Mixture","volume":"5","author":"Parmar S. H.","year":"2018","unstructured":"Parmar, S. H.; Luhar, S. V.; Narkhede, S. B. Development and Validation of UV-Spectroscopic First Derivative and High-Performance Thin Layer Chromatography Analytical Methods for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate and Saxagliptin Hydrochloride in Synthetic Mixture. Eur. J. Biomed. Pharm. Sci. 2018, 5, 668\u2013681.","journal-title":"Eur. J. Biomed. Pharm. Sci."},{"key":"e_1_3_3_143_1","first-page":"2536","article-title":"Spectophotometric Method Development for the Estimation of Saxagliptin and Dapagliflozin in Bulk and Formulation","volume":"9","author":"Kumar P. A.","year":"2020","unstructured":"Kumar, P. A.; Lavakesh, O.; Pushpendra, S. Spectophotometric Method Development for the Estimation of Saxagliptin and Dapagliflozin in Bulk and Formulation. J. Med. Pharmaceutic. All. Sci. 2020, 9, 2536\u20132543.","journal-title":"J. Med. Pharmaceutic. All. Sci."},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.4172\/2153-2435.1000579"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.12"},{"key":"e_1_3_3_146_1","article-title":"Estimation of Saxagliptin Hydrochloride and Dapagliflozin Propendiol Monohydrate in Combined Dosage Form","volume":"3","author":"Asim M.","year":"2018","unstructured":"Asim, M.; Suthar, L. Estimation of Saxagliptin Hydrochloride and Dapagliflozin Propendiol Monohydrate in Combined Dosage Form. J. Innov. Appl. Pharmaceut. Sci. (JIAPS) 2018, 3.","journal-title":"J. Innov. Appl. Pharmaceut. Sci. (JIAPS)"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.61096\/ijpar.v8.iss1.2019.59-66"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2019.104560"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1515\/cipms-2018-0009"},{"key":"e_1_3_3_150_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.12"},{"key":"e_1_3_3_151_1","unstructured":"Reddy Mallu U. A study of new method developmentvalidation and forced degradation for simultaneous analysis of dapagliflozin and saxagliptin in pharmaceutical dosage form by hplc method. 2017."},{"key":"e_1_3_3_152_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjps.galenos.2018.46547"},{"key":"e_1_3_3_153_1","article-title":"A Highly Validated RP-HPLC Method Development for the Simultaneous Estimation of Dapagliflozin and Saxagliptin in Tablet Dosage Forms","volume":"10","author":"Sivagami B.","year":"2018","unstructured":"Sivagami, B.; Padmaja, B. R.; Babu, M. N. A Highly Validated RP-HPLC Method Development for the Simultaneous Estimation of Dapagliflozin and Saxagliptin in Tablet Dosage Forms. Intern. J. Pharmaceut. Sci. Drug Res. 2018, 10.","journal-title":"Intern. J. Pharmaceut. Sci. Drug Res."},{"key":"e_1_3_3_154_1","first-page":"243","article-title":"Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Saxagliptin by RP-HPLC Method","volume":"6","author":"Lakshmi G. V.","year":"2020","unstructured":"Lakshmi, G. V.; Narendra, D. Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Saxagliptin by RP-HPLC Method. World J. Pharm. Med. Res. 2020, 6, 243\u2013248.","journal-title":"World J. Pharm. Med. Res."},{"key":"e_1_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902019000218129"},{"key":"e_1_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v20i6.19"},{"key":"e_1_3_3_157_1","doi-asserted-by":"publisher","DOI":"10.1039\/C8AY02087F"},{"key":"e_1_3_3_158_1","first-page":"19","article-title":"Development and Validation of UV\u2013Vis Spectroscopy Method for Simultaneous Estimation of Saxagliptin Hydrochloride and Metformin Hydrochloride in Active Pharmaceutical Ingredient","volume":"3","author":"Nyola N.","year":"2012","unstructured":"Nyola, N.; Govindasamy, J. Development and Validation of UV\u2013Vis Spectroscopy Method for Simultaneous Estimation of Saxagliptin Hydrochloride and Metformin Hydrochloride in Active Pharmaceutical Ingredient. J. Pharm. Ed. Res. 2012, 3, 19\u201323.","journal-title":"J. Pharm. Ed. Res."},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.21276\/ijcpa"},{"key":"e_1_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmv106"},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bfopcu.2017.04.002"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.13"},{"key":"e_1_3_3_163_1","doi-asserted-by":"publisher","DOI":"10.30574\/gscbps.2020.12.3.0296"},{"key":"e_1_3_3_164_1","first-page":"649","article-title":"Stability-Indicating RP-HPLC Method and Its Validation for Analysis of Metformin Hydrochloride and Saxagliptin in Bulk and Pharmaceutical Dosage Form","volume":"4","author":"Rao N. S.","year":"2015","unstructured":"Rao, N. S.; Venkataramana, K. Stability-Indicating RP-HPLC Method and Its Validation for Analysis of Metformin Hydrochloride and Saxagliptin in Bulk and Pharmaceutical Dosage Form. World J. Pharm. Res. 2015, 4, 649\u2013662.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_165_1","unstructured":"Kaushal A.; Singh S.; Arora S.; Sharma N. A cost effective RP-HPLC method for simultaneous quantitative analysis of saxagliptin and metformin hydrochloride. 2020."},{"key":"e_1_3_3_166_1","first-page":"2729","article-title":"Validated Stability-Indicating Assay Uhplc Method for Simultaneous Analysis of Saxagliptin and Metformin in Fixed-Dose Combinations","volume":"12","author":"Umbarkar R. P.","year":"2022","unstructured":"Umbarkar, R. P.; Mittal, A.; Charde, M. S. Validated Stability-Indicating Assay Uhplc Method for Simultaneous Analysis of Saxagliptin and Metformin in Fixed-Dose Combinations. Biointerf. Res. Appl. Chem. 2022, 12, 2729\u20132744.","journal-title":"Biointerf. Res. Appl. Chem."},{"key":"e_1_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2018v10i3.25261"},{"key":"e_1_3_3_168_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.57.2.69"},{"key":"e_1_3_3_169_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i59A34326"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5384"},{"key":"e_1_3_3_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2019.104017"},{"key":"e_1_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5675.2016.00012.0"},{"key":"e_1_3_3_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103111"},{"key":"e_1_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i58A34159"},{"key":"e_1_3_3_175_1","doi-asserted-by":"crossref","unstructured":"Rane S. S.; Chaudhari R. Y.; Patil V. R.; Barde L. G. ISSN: Applied for Development and validation of UV spectrophotometric method for simultaneous estimation of Empagliflozin and Linagliptin in bulk drugs and pharmaceutical dosage form. 2021.","DOI":"10.52711\/2321-581X.2022.00013"},{"key":"e_1_3_3_176_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5102"},{"key":"e_1_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00764-020-00074-5"},{"key":"e_1_3_3_178_1","doi-asserted-by":"publisher","DOI":"10.1556\/1326.2016.00089"},{"key":"e_1_3_3_179_1","first-page":"1062","article-title":"Simultaneous Estimation of Empagliflozin and Linagliptin by RP-HPLC Method","volume":"7","author":"Bakshi A.","year":"2018","unstructured":"Bakshi, A.; Mounika, A.; Bhutada, S.; B.; Raju Simultaneous Estimation of Empagliflozin and Linagliptin by RP-HPLC Method. Method 2018, 7, 1062.","journal-title":"Method"},{"key":"e_1_3_3_180_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2018v10i3.24662"},{"key":"e_1_3_3_181_1","doi-asserted-by":"publisher","DOI":"10.53730\/ijhs.v6nS3.7166"},{"key":"e_1_3_3_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2018.11.015"},{"key":"e_1_3_3_183_1","doi-asserted-by":"publisher","DOI":"10.5530\/phm.2017.8.19"},{"key":"e_1_3_3_184_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5675.2017.00013.8"},{"key":"e_1_3_3_185_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.59566\/IJBS.2013.9041","article-title":"Spectrophotometric Methods for the Determination of Linagliptin in Binary Mixture with Metformin Hydrochloride and Simultaneous Determination of Linagliptin and Metformin Hydrochloride Using High-Performance Liquid Chromatography","volume":"9","author":"El-Bagary R. I.","year":"2013","unstructured":"El-Bagary, R. I.; Elkady, E. F.; Ayoub, B. M. Spectrophotometric Methods for the Determination of Linagliptin in Binary Mixture with Metformin Hydrochloride and Simultaneous Determination of Linagliptin and Metformin Hydrochloride Using High-Performance Liquid Chromatography. Int. J. Biomed. Sci. 2013, 9, 41\u201347.","journal-title":"Int. J. Biomed. Sci."},{"key":"e_1_3_3_186_1","first-page":"317","article-title":"Development and Validation of HPTLC Method for Simultaneous Estimation and Stability-Indicating Study of Metformin HCl and Linagliptin in Pharmaceutical Formulation","volume":"2","author":"Rajasekaran A.","year":"2014","unstructured":"Rajasekaran, A.; Kavitha, R.; Arivukkarasu, R. Development and Validation of HPTLC Method for Simultaneous Estimation and Stability-Indicating Study of Metformin HCl and Linagliptin in Pharmaceutical Formulation. World J. Pharm. Sci. 2014, 2, 317\u2013327.","journal-title":"World J. Pharm. Sci."},{"key":"e_1_3_3_187_1","doi-asserted-by":"publisher","DOI":"10.4103\/2231-4040.150368"},{"key":"e_1_3_3_188_1","unstructured":"Varaprasad C.; Ramakrishna K. RP-HPLC Method for Simultaneous Estimation of Metformin and Linagliptin in Tablet Dosage Form. 8 426\u2013432."},{"key":"e_1_3_3_189_1","first-page":"202","article-title":"Bioanalytical Method Development and Validation for Simultaneous Determination of Linagliptin and Metformin Drugs in Human Plasma by RP-HPLC Method","volume":"5","author":"Pandya R. H.","year":"2014","unstructured":"Pandya, R. H.; Rathod, R.; Maheswari, D. G. Bioanalytical Method Development and Validation for Simultaneous Determination of Linagliptin and Metformin Drugs in Human Plasma by RP-HPLC Method. Pharmacophore 2014, 5, 202.","journal-title":"Pharmacophore"},{"key":"e_1_3_3_190_1","first-page":"4","article-title":"Simultaneous Determination of Metformin Hydrochloride and Linagliptin by rp-Hplc in Bulk and Pharmaceutical Formulations","volume":"2014","author":"Moncy S.","year":"2014","unstructured":"Moncy, S.; R.; Reddy, M. G.; Sunil Kumar Chaitanya, P.; GPriyanka, H.; Bindu.; et al. Simultaneous Determination of Metformin Hydrochloride and Linagliptin by rp-Hplc in Bulk and Pharmaceutical Formulations. Indo Am. J. Pharmaceut. Res. 2014, 2014, 4.","journal-title":"Indo Am. J. Pharmaceut. Res."},{"key":"e_1_3_3_191_1","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm85030025"},{"key":"e_1_3_3_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.09.052"},{"key":"e_1_3_3_193_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.56.4s.213"},{"key":"e_1_3_3_194_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmab030"},{"key":"e_1_3_3_195_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.22159\/ijap.2022v14i2.43626","article-title":"A. New Validated Stability-Indicating rp-Hplc Method for the Simultaneous Determination of Metformin Hydrochloride, Linagliptin and Empagliflozin in Bulk and Pharmaceutical Dosage Forms","volume":"14","author":"Unade T. T.","year":"2022","unstructured":"Unade, T. T.; Pawar, K. A. New Validated Stability-Indicating rp-Hplc Method for the Simultaneous Determination of Metformin Hydrochloride, Linagliptin and Empagliflozin in Bulk and Pharmaceutical Dosage Forms. Intern. J. Appl. Pharmaceut. 2022, 14, 68\u201376.","journal-title":"Intern. J. Appl. Pharmaceut."},{"key":"e_1_3_3_196_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00332-1"},{"key":"e_1_3_3_197_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5RA17231D"},{"key":"e_1_3_3_198_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5019"},{"key":"e_1_3_3_199_1","doi-asserted-by":"publisher","DOI":"10.3329\/bpj.v18i2.24316"},{"key":"e_1_3_3_200_1","doi-asserted-by":"publisher","DOI":"10.21608\/rpbs.2020.29159.1059"},{"key":"e_1_3_3_201_1","article-title":"Development and Validation of uv Spectrophotometric Method for the Simultaneous Estimation of Vildagliptin and Metformin in Bulk Drugs and Pharmaceutical Dosage Form","volume":"10","author":"Narkhede M. T.","year":"2021","unstructured":"Narkhede, M. T.; Rane, S. S.; Chaudhari, R. Y.; Patil, V. R. Development and Validation of uv Spectrophotometric Method for the Simultaneous Estimation of Vildagliptin and Metformin in Bulk Drugs and Pharmaceutical Dosage Form. World J. Pharm. Res. 2021, 10.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_202_1","unstructured":"Shrikrishna B.; Ms V. S RN. Simultaneous spectrophotometric estimation of vildagliptin and metformin in bulk and tablet dosage form [Internet]. 2013. Available from: www.derpharmachemica.com."},{"key":"e_1_3_3_203_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2018v10i1.20555"},{"key":"e_1_3_3_204_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.9"},{"key":"e_1_3_3_205_1","doi-asserted-by":"publisher","DOI":"10.1556\/1326.2019.00555"},{"key":"e_1_3_3_206_1","first-page":"471","article-title":"RP-HPLC Method Development and Validation for Determination of Metformin and Vildagliptin in Tablet Dosage Form","volume":"15","author":"Godge R. K.","year":"2023","unstructured":"Godge, R. K.; Shinde, G. S.; Mankar, S. D. RP-HPLC Method Development and Validation for Determination of Metformin and Vildagliptin in Tablet Dosage Form. Biol. Forum-An Intern. J. 2023, 15, 471\u2013474.","journal-title":"Biol. Forum-An Intern. J."},{"key":"e_1_3_3_207_1","first-page":"78","article-title":"Asian Journal of Chemical and Pharmaceutical Research Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Vildagliptin by RP-HPLC Method in Bulk and Pharmaceutical Dosage Form","volume":"4","author":"Venkateshwarlu P.","year":"2016","unstructured":"Venkateshwarlu, P.; Shankar, C. H. Asian Journal of Chemical and Pharmaceutical Research Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Vildagliptin by RP-HPLC Method in Bulk and Pharmaceutical Dosage Form. Asian J. Chem. Pharmaceut. Res. 2016, 4, 78\u201383.","journal-title":"Asian J. Chem. Pharmaceut. Res."},{"key":"e_1_3_3_208_1","first-page":"296","article-title":"D. Simultaneous Estimation of Vildagliptin and Metformin Hydrochloride by Using RP-HPLC in Bulk and Pharmaceutical Dosage Form","volume":"8","author":"Karunakar P.","year":"2019","unstructured":"Karunakar, P.; Jonnakuti, C. B.; Raju, A. N. D. Simultaneous Estimation of Vildagliptin and Metformin Hydrochloride by Using RP-HPLC in Bulk and Pharmaceutical Dosage Form. Pharma Innovat. J. 2019, 8, 296\u2013301.","journal-title":"Pharma Innovat. J."},{"key":"e_1_3_3_209_1","first-page":"22","article-title":"Validated Method for the Simultaneous Estimation of Metformin Hydrochloride and Vildagliptin by RP-HPLC in Bulk and Pharmaceutical Dosage Form","volume":"2","author":"Anisetti R. N.","year":"2012","unstructured":"Anisetti, R. N.; Santhosha, B.; Chodavarapu, S. Validated Method for the Simultaneous Estimation of Metformin Hydrochloride and Vildagliptin by RP-HPLC in Bulk and Pharmaceutical Dosage Form. Int. Res. J. Pharm. Appl. Sci. 2012, 2, 22\u201328.","journal-title":"Int. Res. J. Pharm. Appl. Sci."},{"key":"e_1_3_3_210_1","doi-asserted-by":"publisher","DOI":"10.31782\/IJCRR.2021.13710"},{"key":"e_1_3_3_211_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1354373"},{"key":"e_1_3_3_212_1","doi-asserted-by":"publisher","DOI":"10.5530\/jyp.2014.4.7"},{"key":"e_1_3_3_213_1","first-page":"95","article-title":"Development and Validation of RP-HPLC Method for Simultaneous Estimation of Vildagliptin and Metformin","volume":"5","author":"Shrikrishna B.","year":"2013","unstructured":"Shrikrishna, B.; Sugandha, V.; N. S.; Ranpise. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Vildagliptin and Metformin. Res. J. Pharma. Dosage Form. Tech. 2013, 5, 95\u201398.","journal-title":"Res. J. Pharma. Dosage Form. Tech."},{"key":"e_1_3_3_214_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360X.2021.00717"},{"key":"e_1_3_3_215_1","first-page":"1755","article-title":"RP-UPLC Method Development and Validation for Simultaneous Estimation of Vildagliptin with Metformin Hydrochloride and Ciprofloxacin Hydrochloride with Dexamethasone Sodium Phosphate","volume":"3","author":"Fouad M. M.","year":"2015","unstructured":"Fouad, M. M. RP-UPLC Method Development and Validation for Simultaneous Estimation of Vildagliptin with Metformin Hydrochloride and Ciprofloxacin Hydrochloride with Dexamethasone Sodium Phosphate. World J. Pharm. Sci. 2015, 3, 1755\u20131762.","journal-title":"World J. Pharm. Sci."},{"key":"e_1_3_3_216_1","first-page":"203","article-title":"HPLC-MS\/MS Method for Simultaneous Quantification of Vildagliptin, Metformin, and Metformin-Related Compounds in Tablets","volume":"6","author":"Uber C. P.","year":"2014","unstructured":"Uber, C. P.; Pontes, F. L. D.; Gasparetto, J. C.; Francisco, T. M. G.; Piantavini, M. S.; Cardoso, M. A.; Pontarolo, R. HPLC-MS\/MS Method for Simultaneous Quantification of Vildagliptin, Metformin, and Metformin-Related Compounds in Tablets. Int. J. Pharm. Pharm. Sci. 2014, 6, 203\u2013207.","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2014.06.023"},{"key":"e_1_3_3_218_1","doi-asserted-by":"publisher","DOI":"10.25135\/jcm.82.2301.2693"},{"key":"e_1_3_3_219_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26206160"},{"key":"e_1_3_3_220_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2022.v14ti.42"},{"key":"e_1_3_3_221_1","first-page":"611","article-title":"Development and Validation of High Performance Liquid Chromatograohy Method for Simultaneous Estimation of Remogliflozin Etabonate and Vildagliptin in Pharmaceutical Dosage Form","volume":"11","author":"Dhara V.","year":"2015","unstructured":"Dhara, V.; Hetvi, C. Development and Validation of High Performance Liquid Chromatograohy Method for Simultaneous Estimation of Remogliflozin Etabonate and Vildagliptin in Pharmaceutical Dosage Form. World J. Pharm. Res. 2015, 11, 611.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_222_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i40B32296"},{"key":"e_1_3_3_223_1","first-page":"930","article-title":"Development and Validation of Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Remogliflozin and Vildagliptin in Pharmaceutical Dosage Form","volume":"7","author":"Patel R. V.","year":"2022","unstructured":"Patel, R. V.; Panchal, H.; Patel, F.; Patel, A. Development and Validation of Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Remogliflozin and Vildagliptin in Pharmaceutical Dosage Form. Int. J. Nov. Res. Dev. 2022, 7, 930\u2013964.","journal-title":"Int. J. Nov. Res. Dev."},{"key":"e_1_3_3_224_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.56.2.79"},{"key":"e_1_3_3_225_1","doi-asserted-by":"publisher","DOI":"10.5530\/ctbp.2021.4.41"},{"key":"e_1_3_3_226_1","first-page":"3718","article-title":"Novel Stability Indicating LC-MS\/MS Method for the Simultaneous Estimation of Remogliflozin Etabonate and Vildagliptin Human Plasma","volume":"10","author":"Prudhvi S. N.","year":"2021","unstructured":"Prudhvi, S. N.; Venkateswarlu, B. S.; Kumudhavalli, M. V.; Muruganantham, V. Novel Stability Indicating LC-MS\/MS Method for the Simultaneous Estimation of Remogliflozin Etabonate and Vildagliptin Human Plasma. J. Med. Pharmaceut. All. Sci. 2021, 10, 3718\u20133725.","journal-title":"J. Med. Pharmaceut. All. Sci."},{"key":"e_1_3_3_227_1","doi-asserted-by":"crossref","unstructured":"Patel V. S.; Kapupara P.; Bhangale J. O. Stability Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin and Vildagliptin in Pharmaceutical Dosage Form Stability Indicating rp-Hplc Method for Simultaneous Estimation of Dapagliflozin and Vildagliptin in Pharmaceutical Dosage Form. 2023 1918\u20131930.","DOI":"10.9734\/bpi\/caprd\/v8\/15564D"},{"key":"e_1_3_3_228_1","first-page":"847","article-title":"A Revised RP-HPLC Method for Simultaneous Determination of Vildagliptin and Pioglitazone HCl-Application to Commercially Available Drug Products","volume":"4","author":"Inamdar H. P.","year":"2013","unstructured":"Inamdar, H. P.; Mhaske, A. A.; Sahastrabudhe, S. P. A Revised RP-HPLC Method for Simultaneous Determination of Vildagliptin and Pioglitazone HCl-Application to Commercially Available Drug Products. IJPSR 2013, 4, 847\u2013855.","journal-title":"IJPSR"},{"key":"e_1_3_3_229_1","doi-asserted-by":"publisher","DOI":"10.9790\/3008-1202041827"},{"key":"e_1_3_3_230_1","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2023.136050"},{"key":"e_1_3_3_231_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00983-6"},{"key":"e_1_3_3_232_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13738-020-02065-z"},{"key":"e_1_3_3_233_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167107"},{"key":"e_1_3_3_234_1","unstructured":"Parle A. Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Metformin Hydrochloride and Alogliptin Benzoate in Bulk Drugs and Combined Dosage Forms. 2014"},{"key":"e_1_3_3_235_1","first-page":"380","article-title":"Determination of Alogliptin Benzoate and Metformin Hydrochloride in Tablet Dosage Form by Simultaneous Equation and Absorption Ratio Method","volume":"7","author":"Sen D.","year":"2015","unstructured":"Sen, D.; Sen, A.; Zanwar, A.; Balaraman, R.; Seth, D. Determination of Alogliptin Benzoate and Metformin Hydrochloride in Tablet Dosage Form by Simultaneous Equation and Absorption Ratio Method. Int J. Pharm. Pharm. Sci. 2015, 7, 380\u2013383.","journal-title":"Int J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_236_1","first-page":"1329","article-title":"Simultaneous Estimation of Alogliptin and Metformin from Its Tablet Dosage Form by Area under Curve and Multicomponent UV Spectrophotometric Method","volume":"4","author":"Nikalje A.","year":"2015","unstructured":"Nikalje, A.; Baig, M. S.; Anees, M. I.; Qureshi, A. Simultaneous Estimation of Alogliptin and Metformin from Its Tablet Dosage Form by Area under Curve and Multicomponent UV Spectrophotometric Method. World J. Pharm. Pharm. Sci. 2015, 4, 1329\u20131339.","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_237_1","article-title":"Chemometrics Assisted Simultaneous Spectrophotometric Determination of Alogliptin and Metformin in Pharmaceutical Dosage Form","volume":"7","author":"Pk B.","year":"2018","unstructured":"Pk, B.; Sm, S.; Banu, S. Chemometrics Assisted Simultaneous Spectrophotometric Determination of Alogliptin and Metformin in Pharmaceutical Dosage Form. Iran. J. Chem. Chem. Eng. (IJCCE). 2018, 7.","journal-title":"Iran. J. Chem. Chem. Eng. (IJCCE)."},{"key":"e_1_3_3_238_1","unstructured":"Sandhya M Vijaya Vani CS. Development and Validation of UV Spectroscopic Method for the Determination of Alogliptin Benzoate and Metformin Hydrochloride in bulk and Tablet Dosage Form. 2020."},{"key":"e_1_3_3_239_1","unstructured":"Swarnkar P Gupta MK Maheshwari M. Method Development for the Simultaneous Analysis of Metformin and Alogliptin by Using UV-Visible Spectrophotometer. 2022."},{"key":"e_1_3_3_240_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijpps.2020v12i12.33871"},{"key":"e_1_3_3_241_1","first-page":"321","article-title":"Scholar Research Library Development and Validation of HPTLC Method for Simultaneous Estimation of Metformin Hydrochloride and Alogliptin Benzoate in Bulk Drugs and Combined Dosage Forms","volume":"7","author":"Sharma K.","year":"2015","unstructured":"Sharma, K.; Parle, A.; Ahmad, S. Scholar Research Library Development and Validation of HPTLC Method for Simultaneous Estimation of Metformin Hydrochloride and Alogliptin Benzoate in Bulk Drugs and Combined Dosage Forms. Scholar. Res. Lib. Der Pharmacia Lettr. 2015, 7, 321\u2013328.","journal-title":"Scholar. Res. Lib. Der Pharmacia Lettr."},{"key":"e_1_3_3_242_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202000937"},{"key":"e_1_3_3_243_1","doi-asserted-by":"publisher","DOI":"10.52711\/2349-2988.2021.00017"},{"key":"e_1_3_3_244_1","unstructured":"Runja C.; Ravikumar P.; R.; Avanapu Stability Indicating RP-HPLC Method for Simultaneous Estimation of Alogliptin Benzoate and Metformin Hydrochloride in Tablet Dosage Form. 2016."},{"key":"e_1_3_3_245_1","first-page":"319","article-title":"Development and Validation of Stabilty Indicating RP-HPLC Method for Simultaneous Estimation of Metformin and Alogliptin in Bulk and Tablet Dosage Form. \u223c 319 \u223c","volume":"7","author":"Sultana N.","year":"2018","unstructured":"Sultana, N.; Rizwana, I. Development and Validation of Stabilty Indicating RP-HPLC Method for Simultaneous Estimation of Metformin and Alogliptin in Bulk and Tablet Dosage Form. \u223c 319 \u223c. Pharma Innov. J. 2018, 7, 319\u2013324.","journal-title":"Pharma Innov. J."},{"key":"e_1_3_3_246_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7064.1000293"},{"key":"e_1_3_3_247_1","article-title":"Method Development for the Simultaneous Estimation of Metformin and Alogliptin by Using RP-HPLC","author":"Swathi K.","year":"2015","unstructured":"Swathi, K.; Chaitanya, M. Method Development for the Simultaneous Estimation of Metformin and Alogliptin by Using RP-HPLC. Int. J. Pharma Res. Health Sci. 2015,","journal-title":"Int. J. Pharma Res. Health Sci."},{"key":"e_1_3_3_248_1","first-page":"1450","article-title":"Development and Validation of rp-Hplc Method for Estimation of Antidiabetic Drugs Alogliptin Benzoate and Metformin HCl in Pharmaceutical Formulation","volume":"8","author":"Patil K. R.","year":"2019","unstructured":"Patil, K. R.; Deshmukh, T. A.; Patil, V. R. Development and Validation of rp-Hplc Method for Estimation of Antidiabetic Drugs Alogliptin Benzoate and Metformin HCl in Pharmaceutical Formulation. World J. Pharm. Res. 2019, 8, 1450.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_249_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i4.3093"},{"key":"e_1_3_3_250_1","first-page":"196","article-title":"Simultaneous Assessment of Alogliptin Benzoate and Metformin Hydrochloride in Tablet Dosage Form by Reversed-Phase High-Performance Liquid Chromatography","volume":"16","author":"Sen D. B.","year":"2022","unstructured":"Sen, D. B.; Sen, A. K.; Zanwar, A.; Patel, K. P.; Balaraman, R.; Maheshwari, R. A.; Aundhia, C. Simultaneous Assessment of Alogliptin Benzoate and Metformin Hydrochloride in Tablet Dosage Form by Reversed-Phase High-Performance Liquid Chromatography. Asian J. Pharm. 2022, 16, 196\u2013202.","journal-title":"Asian J. Pharm."},{"key":"e_1_3_3_251_1","unstructured":"Swarnkar P.; Kumar Gupta M. An Efficient Method for Simultaneous Estimation of Alogliptin and Metformin in Pharmaceutical Dosage Form by Using RP-HPLC. 2021"},{"key":"e_1_3_3_252_1","first-page":"1","article-title":"Analytical Method Development and Validation of Alogliptin and Metformin Hydrochloride Tablet Dosage Form by RP-HPLC Method","volume":"5","author":"Kumar A. P.","year":"2013","unstructured":"Kumar, A. P.; Aruna, G.; Rajasekar, K.; Reddy, P. J. C. Analytical Method Development and Validation of Alogliptin and Metformin Hydrochloride Tablet Dosage Form by RP-HPLC Method. Int J. Pharm. Pharm. Sci. 2013, 5, 1\u20136.","journal-title":"Int J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_253_1","doi-asserted-by":"publisher","DOI":"10.53879\/id.58.05.11771"},{"key":"e_1_3_3_254_1","doi-asserted-by":"publisher","DOI":"10.36468\/pharmaceutical-sciences.830"},{"key":"e_1_3_3_255_1","doi-asserted-by":"publisher","DOI":"10.31080\/ASPS.2022.06.0918"},{"key":"e_1_3_3_256_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2016.10.002"},{"key":"e_1_3_3_257_1","doi-asserted-by":"publisher","DOI":"10.31083\/ph.2017.6151"},{"key":"e_1_3_3_258_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i37B32017"},{"key":"e_1_3_3_259_1","doi-asserted-by":"publisher","DOI":"10.1080\/22297928.2018.1442246"},{"key":"e_1_3_3_260_1","article-title":"Development and Validation of Hplc Method for the Simultaneous Estimation of Pioglitazone and Alogliptin in Bulk and Dosage Form","volume":"6","author":"Kashyap R.","year":"2014","unstructured":"Kashyap, R.; Srinivasa, U. Development and Validation of Hplc Method for the Simultaneous Estimation of Pioglitazone and Alogliptin in Bulk and Dosage Form. Int. J. Curr. Res. 2014, 6.","journal-title":"Int. J. Curr. Res."},{"key":"e_1_3_3_261_1","article-title":"Simultaneous Determination of Alogliptin and Pioglitazone in Combined Tablet Dosage Form by RP-HPLC Method","volume":"21","author":"Haribabu B.","year":"2017","unstructured":"Haribabu, B.; Rama Krishna Veni, P.; Bala Murali Krishna, K.; Prameela, L. K. Simultaneous Determination of Alogliptin and Pioglitazone in Combined Tablet Dosage Form by RP-HPLC Method. Marmara. Pharm. J. 2017, 21.","journal-title":"Marmara. Pharm. J."},{"key":"e_1_3_3_262_1","unstructured":"Sundar S.; Raja A.; Dutt K. R.; Knv R.; Vasanthi R.; Noori K.; et al. Development of Rapid Stability Indicating Method for Simultaneous Estimation of Alogliptin and Pioglitazone in Bulk and Combined Dosage Form by rp-Hplc Method. 2017"},{"key":"e_1_3_3_263_1","article-title":"Method Development and Validation of Alogliptin and Pioglitazone by RP-Hplc Method in Bulk and Its Marketed Dosage Form","volume":"10","author":"Kandala M.","year":"2021","unstructured":"Kandala, M.; Mounika, R.; Sultana, S.; Hogue, N.; Ali, S.; Prashanthi, S.; et al. Method Development and Validation of Alogliptin and Pioglitazone by RP-Hplc Method in Bulk and Its Marketed Dosage Form. World J. Pharm. Res. 2021, 10.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_264_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpps20177-9466"},{"key":"e_1_3_3_265_1","first-page":"172","article-title":"A New Separation Technique for Method Development and Validation of Alogliptin and Pioglitazone in Its Pure and Pharmaceutical Dosage Form by RP-HPLC Method","volume":"5","author":"Begum H.","year":"2019","unstructured":"Begum, H.; Vani, R.; Krishna, R. D. A New Separation Technique for Method Development and Validation of Alogliptin and Pioglitazone in Its Pure and Pharmaceutical Dosage Form by RP-HPLC Method. World J. Pharm. Life Sci. 2019, 5, 172\u2013178.","journal-title":"World J. Pharm. Life Sci."},{"key":"e_1_3_3_266_1","first-page":"458","article-title":"A Validated Stability Indicating rp-Hplc Method for Simultaneous Determination of Alogliptine and Pioglitazone in Bulk and Pharmaceutical Formulations","volume":"4","author":"Neelima B.","year":"2014","unstructured":"Neelima, B.; Ravi Kumar, P.; Bindu, V. H.; Prasad, R. Y. A Validated Stability Indicating rp-Hplc Method for Simultaneous Determination of Alogliptine and Pioglitazone in Bulk and Pharmaceutical Formulations. Int J. Pharm. 2014, 4, 458\u2013464.","journal-title":"Int J. Pharm."},{"key":"e_1_3_3_267_1","article-title":"An Effective Chromatographic Method for Simultaneous Quantification of Antidiabetic Drugs Alogliptin Benzoate and Pioglitazone HCl in Their Tablet Dosage Form: Implementation to In Vitro Dissolution Studies and Uniformity of Dosage Unit","author":"Mohamed M. A.","year":"2022","unstructured":"Mohamed, M. A. An Effective Chromatographic Method for Simultaneous Quantification of Antidiabetic Drugs Alogliptin Benzoate and Pioglitazone HCl in Their Tablet Dosage Form: Implementation to In Vitro Dissolution Studies and Uniformity of Dosage Unit. J. Chromatogr. Sci. 2022.","journal-title":"J. Chromatogr. Sci"},{"key":"e_1_3_3_268_1","first-page":"99","article-title":"Stability Indicating RP-Hplc Method for Simultaneous Estimation of Pioglitazone Hydrochloride and Alogliptin Benzoate in Pharmaceutical Formulation","volume":"6","author":"Kumar H.","year":"2016","unstructured":"Kumar, H.; Sankar, G. Stability Indicating RP-Hplc Method for Simultaneous Estimation of Pioglitazone Hydrochloride and Alogliptin Benzoate in Pharmaceutical Formulation. Int J. Pharm. 2016, 6, 99\u2013111.","journal-title":"Int J. Pharm."},{"key":"e_1_3_3_269_1","doi-asserted-by":"publisher","DOI":"10.21608\/odr.2022.170000.1018"},{"key":"e_1_3_3_270_1","article-title":"Development and Validation of a Novel RP-HPLC Method for Simultaneous Estimation of Alogliptin Benzoate and Pioglitazone Hcl in Pharmaceutical Dosage Form","volume":"4","author":"Potdar K. S.","year":"2017","unstructured":"Potdar, K. S.; Kalshetti, M. S.; Patil, R. Y. Development and Validation of a Novel RP-HPLC Method for Simultaneous Estimation of Alogliptin Benzoate and Pioglitazone Hcl in Pharmaceutical Dosage Form. Intern. J. Chem. Pharmaceut. Anal. 2017, 4.","journal-title":"Intern. J. Chem. Pharmaceut. Anal."},{"key":"e_1_3_3_271_1","doi-asserted-by":"crossref","first-page":"051","DOI":"10.7324\/JAPS.2019.91208","article-title":"Development of Stability Indicating Method for the Simultaneous Estimation of Alogliptin and Pioglitazone in Bulk and Tablet Dosage Form by Reversed-Phase Ultra-Performance Liquid Chromatography Method","volume":"9","author":"Dhani R.","year":"2019","unstructured":"Dhani, R.; Guptha, H. K. D. R.; Rajamanickam, D. Development of Stability Indicating Method for the Simultaneous Estimation of Alogliptin and Pioglitazone in Bulk and Tablet Dosage Form by Reversed-Phase Ultra-Performance Liquid Chromatography Method. J. Appl. Pharm. Sci. 2019, 9, 051\u2013056.","journal-title":"J. Appl. Pharm. Sci."},{"key":"e_1_3_3_272_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2017.04.043"},{"key":"e_1_3_3_273_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.121803"},{"key":"e_1_3_3_274_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412915666190314143424"},{"key":"e_1_3_3_275_1","doi-asserted-by":"publisher","DOI":"10.32383\/appdr\/125774"},{"key":"e_1_3_3_276_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9872.1000354"},{"key":"e_1_3_3_277_1","article-title":"Spectrophotometric Estimation of Glibenclamide and Alogliptin in Synthetic Mixture by Area under Curve Method","author":"Anjali R.","year":"2016","unstructured":"Anjali, R.; Ppu, V. Spectrophotometric Estimation of Glibenclamide and Alogliptin in Synthetic Mixture by Area under Curve Method. Int. J. Pharm. Pharm. Res. 2016.","journal-title":"Int. J. Pharm. Pharm. Res."},{"key":"e_1_3_3_278_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2020.00104.3"},{"key":"e_1_3_3_279_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2019.03.038"},{"key":"e_1_3_3_280_1","first-page":"119","article-title":"Development and Evaluation of Simple Spectrophotometric Methods for the Simultaneous Determination of Alogliptin Benzoate Metformin Hydrochloride and Melamine","volume":"66","author":"Farid N. F.","year":"2023","unstructured":"Farid, N. F.; Ali, N. W.; Taha, A. A.; Elgebaly, A. M.; Magdy, M. A. Development and Evaluation of Simple Spectrophotometric Methods for the Simultaneous Determination of Alogliptin Benzoate Metformin Hydrochloride and Melamine. Egypt J. Chem. 2023, 66, 119\u2013129.","journal-title":"Egypt J. Chem."},{"key":"e_1_3_3_281_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10337-016-3209-7"},{"key":"e_1_3_3_282_1","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i30B31649"},{"key":"e_1_3_3_283_1","doi-asserted-by":"crossref","unstructured":"Vaishali P. S. Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin and Metformin Hydrochloride. 2021 11.","DOI":"10.35652\/IGJPS.2021.111009"},{"key":"e_1_3_3_284_1","article-title":"Development and Validation of Analytical Method for Simultaneous Estimation of Gemigliptin and Dapagliflozin in Synthetic Mixture","volume":"8","author":"Bhoi A.","year":"2023","unstructured":"Bhoi, A.; Dalwadi, M.; Upadhyay, U. Development and Validation of Analytical Method for Simultaneous Estimation of Gemigliptin and Dapagliflozin in Synthetic Mixture. Int. J. Nov. Res. Dev. 2023, 8.","journal-title":"Int. J. Nov. Res. Dev."},{"key":"e_1_3_3_285_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412915666190523112754"},{"key":"e_1_3_3_286_1","first-page":"4931","article-title":"Development and Validation of First-Order Derivative Spectrophotometric Method for Simultaneous Estimation of Rosuvastatin Calcium and Gemigliptin in Synthetic Mixture","volume":"9","author":"Parekh B. J.","year":"2018","unstructured":"Parekh, B. J.; Shah, J. S.; Maheshwari, D. Development and Validation of First-Order Derivative Spectrophotometric Method for Simultaneous Estimation of Rosuvastatin Calcium and Gemigliptin in Synthetic Mixture. J. Glob. Trend. Pharm. Sci. 2018, 9, 4931\u20134939.","journal-title":"J. Glob. Trend. Pharm. Sci."},{"key":"e_1_3_3_287_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6693366"},{"key":"e_1_3_3_288_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00955-w"},{"key":"e_1_3_3_289_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03855"},{"key":"e_1_3_3_290_1","first-page":"2925","article-title":"First-Order Derivative Spectrophotometric Method for Simultaneous Estimation of Anagliptin and Metformin HCl in Bulk and Synthetic Mixture","volume":"6","author":"Shah S. T.","year":"2015","unstructured":"Shah, S. T.; Maheshwari, D. G. First-Order Derivative Spectrophotometric Method for Simultaneous Estimation of Anagliptin and Metformin HCl in Bulk and Synthetic Mixture. J. Glob. Trend. Pharm. Sci. 2015, 6, 2925\u20132929.","journal-title":"J. Glob. Trend. Pharm. Sci."},{"key":"e_1_3_3_291_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.12"},{"key":"e_1_3_3_292_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpr201711-9630"},{"key":"e_1_3_3_293_1","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2016.60924"},{"key":"e_1_3_3_294_1","doi-asserted-by":"publisher","DOI":"10.7897\/2230-8407.0917"},{"key":"e_1_3_3_295_1","first-page":"965","article-title":"Development and Validation of an UV-Spectrophotometric Method for Simultaneous Estimation of Teneligliptin and Metformin","volume":"7","author":"Ajay Sawaikar L. A.","year":"2018","unstructured":"Ajay Sawaikar, L. A.; Ajay Sawaikar, L. Development and Validation of an UV-Spectrophotometric Method for Simultaneous Estimation of Teneligliptin and Metformin. World J. Pharm. Res. 2018, 7, 965\u2013974.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_296_1","doi-asserted-by":"publisher","DOI":"10.47070\/ijraps.v5i9.120"},{"key":"e_1_3_3_297_1","first-page":"3146","article-title":"RP-HPLC and UV-Spectrophotometric Methods Development and Validation for Simultaneous Estimation of Teneligliptin and Metformin in Fixed Dose Combination","volume":"9","author":"Chabukswar A.","year":"2019","unstructured":"Chabukswar, A.; Sakpal, P. RP-HPLC and UV-Spectrophotometric Methods Development and Validation for Simultaneous Estimation of Teneligliptin and Metformin in Fixed Dose Combination. Curr. Pharm. Res. 2019, 9, 3146\u20133154.","journal-title":"Curr. Pharm. Res."},{"key":"e_1_3_3_298_1","first-page":"1","article-title":"Development and Validation of Dual-Wavelength UV Spectrophotometric Method for Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Combined Dosage Form","volume":"9","author":"Shivlal S.","year":"2018","unstructured":"Shivlal, S.; Patel, V. Development and Validation of Dual-Wavelength UV Spectrophotometric Method for Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Combined Dosage Form. Int. J. Pharm. Sci. Res. 2018, 9, 1\u20136.","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"e_1_3_3_299_1","first-page":"160","article-title":"Simultaneous Estimation of Teneligliptin and Metformin Hydrochloride in Tablet Formulation by UV Spectrophotometric Method","volume":"6","author":"Ms S.","year":"2021","unstructured":"Ms, S.; Goyal, P. K. Simultaneous Estimation of Teneligliptin and Metformin Hydrochloride in Tablet Formulation by UV Spectrophotometric Method. Chem. Res. J. 2021, 6, 160\u2013165.","journal-title":"Chem. Res. J."},{"key":"e_1_3_3_300_1","article-title":"Simultaneous Spectrophotometric Determination of Compounds: Application to an anti-Diabetic Formulation of Teneligliptin and Metformin","volume":"13","author":"Mukthinuthalapati Mathrusri Annapurna RRNSMP","year":"2020","unstructured":"Mukthinuthalapati Mathrusri Annapurna RRNSMP. Simultaneous Spectrophotometric Determination of Compounds: Application to an anti-Diabetic Formulation of Teneligliptin and Metformin. Res. J. Pharm. Technol. 2020, 13.","journal-title":"Res. J. Pharm. Technol."},{"key":"e_1_3_3_301_1","unstructured":"Patel V. A.; Pandya C.; Pandya A.; Kumbhani J.; Patel D.; Patel Z. Concurrent Determination of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride Development and Validation by UV-VIS Spectrophotometry in Bulk and Pharmaceutical Dosage Form. 2019."},{"key":"e_1_3_3_302_1","doi-asserted-by":"publisher","DOI":"10.25135\/jcm.55.20.11.1893"},{"key":"e_1_3_3_303_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.11"},{"key":"e_1_3_3_304_1","doi-asserted-by":"publisher","DOI":"10.53879\/id.55.10.11059"},{"key":"e_1_3_3_305_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00362-9"},{"key":"e_1_3_3_306_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.52711\/0974-360X.2023.00084","article-title":"A Simple, Precise, and Sensitive RP-HPLC Method for Quantification of Teneligliptin Hydrobromide and Metformin Hydrochloride: Development and Validation","volume":"16","author":"Patel M. M.","year":"2023","unstructured":"Patel, M. M.; Patel, D.; Shah, U.; Kachhiya, H. M. A Simple, Precise, and Sensitive RP-HPLC Method for Quantification of Teneligliptin Hydrobromide and Metformin Hydrochloride: Development and Validation. Res. J. Pharm. Technol. 2023, 16, 495\u2013501.","journal-title":"Res. J. Pharm. Technol."},{"key":"e_1_3_3_307_1","doi-asserted-by":"publisher","DOI":"10.20959\/wjpr20178-8977"},{"key":"e_1_3_3_308_1","first-page":"420","article-title":"Development and Validation of rp-Hplc Method for Simultaneous Estimation of Teneligliptin Hemipentahydrobromide Hydrate and Metformin Hydrochloride in Their Combined Tablet Dosage Form","volume":"8","author":"Pandya R. P.","unstructured":"Pandya, R. P.; Sakhreliya, B.; Patani, P. Development and Validation of rp-Hplc Method for Simultaneous Estimation of Teneligliptin Hemipentahydrobromide Hydrate and Metformin Hydrochloride in Their Combined Tablet Dosage Form. Pharma Sci. Monitor. 8, 420\u2013434.","journal-title":"Pharma Sci. Monitor."},{"key":"e_1_3_3_309_1","article-title":"Development and Validation of Analytical Method for Simultaneous Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Pharmaceutical Dosage Form","volume":"8","author":"Patel K. B.","year":"2017","unstructured":"Patel, K. B.; Joshi, H. V.; Shah, U. A.; Patel, J. K. Development and Validation of Analytical Method for Simultaneous Estimation of Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride in Pharmaceutical Dosage Form. Pharma. Sci. Monit. 2017, 8.","journal-title":"Pharma. Sci. Monit."},{"key":"e_1_3_3_310_1","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360X.2023.00025"},{"key":"e_1_3_3_311_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijpps.2017v9i12.21151"},{"key":"e_1_3_3_312_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjps.galenos.2018.16768"},{"key":"e_1_3_3_313_1","doi-asserted-by":"crossref","unstructured":"Joshi H.; Khristi A. Rp-Hplc Method Development and Validation for the Simultaneous Estimation of Teneligliptine Hydrobromide Hydrate (Ten) and Metformin Hydrochloride (Met) in Tablet Dosage Form. 2019 56 49\u201356.","DOI":"10.53879\/id.56.08.11253"},{"key":"e_1_3_3_314_1","first-page":"200","article-title":"Development and Validation of Analytical Method for Simultaneous Estimation of Metformin Hydrochloride and Teneligliptin Hydrobromide Hydrate in Pharmaceutical Dosage Form J Pharm Sci Bioscientific Res","volume":"7","author":"Patil M. D.","year":"2017","unstructured":"Patil, M. D.; Bapna, M.; Shah, P.; Khoja, S. S.; S.; Ks. Development and Validation of Analytical Method for Simultaneous Estimation of Metformin Hydrochloride and Teneligliptin Hydrobromide Hydrate in Pharmaceutical Dosage Form J Pharm Sci Bioscientific Res. J. Pharm. Sci. Bioscient. Res. 2017, 7, 200\u2013108.","journal-title":"J. Pharm. Sci. Bioscient. Res."},{"key":"e_1_3_3_315_1","unstructured":"Balakrishna S.; Sunil P.; Chaitanya K.; Haritha P. N. Development and Validation of a Stability-Indicating rp-Hplc Method for the Simultaneous Quantification of Metformin and Teneligliptin in Solid Dosage Form. 2021."},{"key":"e_1_3_3_316_1","article-title":"RP-HPLC Method Development and Validation for Simultaneous Estimation of Metformin and Teneligliptin in Bulk and Pharmaceutical Dosage Form","volume":"7","author":"Ahmed A.","year":"2019","unstructured":"Ahmed, A.; Patel, T.; Yaasir, A. RP-HPLC Method Development and Validation for Simultaneous Estimation of Metformin and Teneligliptin in Bulk and Pharmaceutical Dosage Form. Intern. J. Res. Advent Tech. [Internet] 2019, 7.","journal-title":"Intern. J. Res. Advent Tech. [Internet]"},{"key":"e_1_3_3_317_1","unstructured":"Barkami A. R. S. A Validated Stability Indicating rp-Hplc Method for Simultaneous Estimation of Metformin and Teneligliptin in Bulk and Pharmaceutical Dosage Form. 2018."},{"key":"e_1_3_3_318_1","first-page":"128","article-title":"Development of Validated Stability-Indicating Chromatographic Method for the Determination of Metformin and Teneligliptin and Its Related Impurities in Pharmaceutical Tablets","volume":"13","author":"Patel S.","year":"2022","unstructured":"Patel, S.; Jagtap, K.; Shah, U.; Patel, D. Development of Validated Stability-Indicating Chromatographic Method for the Determination of Metformin and Teneligliptin and Its Related Impurities in Pharmaceutical Tablets. Intern. J. Pharmaceut. Qual. Assurance 2022, 13, 128\u2013136.","journal-title":"Intern. J. Pharmaceut. Qual. Assurance"},{"key":"e_1_3_3_319_1","article-title":"D. Development of a Novel Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Teneligliptin Hydrobromide in Bulk and Combined Tablet Dosage Forms","volume":"2","author":"Kumaraswamy G.","year":"2017","unstructured":"Kumaraswamy, G.; Parushuramulu, M.; Pranay, K.; Kumar, S. D. Development of a Novel Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Metformin Hydrochloride and Teneligliptin Hydrobromide in Bulk and Combined Tablet Dosage Forms. Innov. Int. J. Med. Pharm. Sci. 2017, 2.","journal-title":"Innov. Int. J. Med. Pharm. Sci."},{"key":"e_1_3_3_320_1","first-page":"8051","article-title":"Analytical Method Development and Validation of Teneligliptin and Metformin HCl by Using RP-HPLC Method","volume":"11","author":"Shirisha K.","year":"2020","unstructured":"Shirisha, K.; Begum, A.; Sravya, K.; Swarna, K.; Neelima, K.; Ssr, K. Analytical Method Development and Validation of Teneligliptin and Metformin HCl by Using RP-HPLC Method. J. Glob. Trend. Pharm. Sci. 2020, 11, 8051\u20138056.","journal-title":"J. Glob. Trend. Pharm. Sci."},{"key":"e_1_3_3_321_1","article-title":"Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Teneligliptin in Bulk and Its Dosage Form Using Rp-Hplc","volume":"7","author":"Fatima K.","year":"2017","unstructured":"Fatima, K.; DrRV, D. Analytical Method Development and Validation for the Simultaneous Estimation of Metformin and Teneligliptin in Bulk and Its Dosage Form Using Rp-Hplc. Indo American Journal of Pharmaceutical Research 2017, 7.","journal-title":"Indo American Journal of Pharmaceutical Research"},{"key":"e_1_3_3_322_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.10"},{"key":"e_1_3_3_323_1","doi-asserted-by":"publisher","DOI":"10.5267\/j.ccl.2021.4.001"},{"key":"e_1_3_3_324_1","article-title":"Simultaneous Determination of Metformin and Teneligliptin by Liquid Chromatography in Tablets","author":"Sunkara Mrunal Chaitanya MMA","year":"2018","unstructured":"Sunkara Mrunal Chaitanya MMA. Simultaneous Determination of Metformin and Teneligliptin by Liquid Chromatography in Tablets. Asian J. Pharm. 2018,","journal-title":"Asian J. Pharm."},{"key":"e_1_3_3_325_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.9"},{"key":"e_1_3_3_326_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2018-0007"},{"key":"e_1_3_3_327_1","doi-asserted-by":"publisher","DOI":"10.53879\/id.55.04.11242"},{"key":"e_1_3_3_328_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2017.05.026"},{"key":"e_1_3_3_329_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S393675"},{"key":"e_1_3_3_330_1","first-page":"149","article-title":"Development and Validation of UV-Spectroscopic Method for Simultaneous Estimation of Remogliflozin Etabonate and Teneligliptin in Bulk and Pharmaceutical Dosage Form by Simultaneous Equation Method","volume":"8","author":"Vashi D.","year":"2022","unstructured":"Vashi, D.; Gamit, D. Development and Validation of UV-Spectroscopic Method for Simultaneous Estimation of Remogliflozin Etabonate and Teneligliptin in Bulk and Pharmaceutical Dosage Form by Simultaneous Equation Method. World J. Pharm. Life Sci. 2022, 8, 149\u2013153.","journal-title":"World J. Pharm. Life Sci."},{"key":"e_1_3_3_331_1","first-page":"173","article-title":"Validation and Forced Degradation Behavior of Teneligliptin and Remogliflozin Etabonate in Section A-Research Paper Combined Dosage Form by RP-HPLC Method Eur","volume":"2023","author":"Dhanabalan K.","unstructured":"Dhanabalan, K.; Rangasamy, M.; Kumar Gopal, S.; Sivalingam, A.; Prasath Jeeva, B.; Venkatesh, D.; et al. Validation and Forced Degradation Behavior of Teneligliptin and Remogliflozin Etabonate in Section A-Research Paper Combined Dosage Form by RP-HPLC Method Eur. Eur. Chem. Bull. 2023, 173\u2013183.","journal-title":"Eur. Chem. Bull."},{"key":"e_1_3_3_332_1","article-title":"Simultaneous Estimation of Remogliflozin Etabonate and Teneligliptin Hydrobromide Hydrate in Tablet Dosage Form by Rp-Hplc Method","author":"Lad H. H.","year":"2023","unstructured":"Lad, H. H.; Luhar, S. V.; Narkhede, S. B. Simultaneous Estimation of Remogliflozin Etabonate and Teneligliptin Hydrobromide Hydrate in Tablet Dosage Form by Rp-Hplc Method. EPRA Intern. J. Res. Develop. (IJRD). 2023.","journal-title":"EPRA Intern. J. Res. Develop. (IJRD)."},{"key":"e_1_3_3_333_1","doi-asserted-by":"publisher","DOI":"10.33289\/IJRPC.13.1.2023.13(15)"},{"key":"e_1_3_3_334_1","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.14"},{"key":"e_1_3_3_335_1","first-page":"1505","article-title":"Development and Validation of rp-Hplc Method for Stimultaneus Estimation of Remogliflozin Etabonate and Teneligliptin in Pharmaceutical Dosage Form","volume":"11","author":"Dhara V.","year":"2015","unstructured":"Dhara, V.; Dharmistha, G. Development and Validation of rp-Hplc Method for Stimultaneus Estimation of Remogliflozin Etabonate and Teneligliptin in Pharmaceutical Dosage Form. World J. Pharm. Pharmaceut. Sci. 2015, 11, 1505.","journal-title":"World J. Pharm. Pharmaceut. Sci."},{"key":"e_1_3_3_336_1","unstructured":"Anchal A. RP-HPLC Method Validation for the Simultaneous Estimation of Remogliflozin and Teneligliptin in Bulk and Pharmaceutical Dosage Form. 2023."},{"key":"e_1_3_3_337_1","first-page":"1916","article-title":"S. Stability Indicating Analytical Method Development and Validation for Simultaneous Estimation of Teneligliptin Hemihydrate Hydrobromide and Rosuvastatin Calcium in Synthetic Mixture","volume":"11","author":"Javedmiya M","year":"2015","unstructured":"Javedmiya M, S Sarkar. S. Stability Indicating Analytical Method Development and Validation for Simultaneous Estimation of Teneligliptin Hemihydrate Hydrobromide and Rosuvastatin Calcium in Synthetic Mixture. World J. Pharm. Pharm. Sci. 2015, 11, 1916\u20131952.","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_338_1","article-title":"Development and Validation of Novel RP-HPLC Method for the Simultaneous Determination of Rosuvastatin and Teneligliptin in Bulk and in Synthetic Mixture","volume":"13","author":"Drashti A.","year":"2021","unstructured":"Drashti, A.; Mandale, D. Development and Validation of Novel RP-HPLC Method for the Simultaneous Determination of Rosuvastatin and Teneligliptin in Bulk and in Synthetic Mixture. Intern. J. Pharmaceut. Res. 2021, 13.","journal-title":"Intern. J. Pharmaceut. Res."},{"key":"e_1_3_3_339_1","unstructured":"Patel F.; Dalwadi P.; Patel M. D.; Mehta N. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Teneligliptin Hydrobromide Hydrtae and Rosuvastatin Calcium in Synthetic Mixture. 2021."},{"key":"e_1_3_3_340_1","first-page":"770","article-title":"Analytical Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Teneligliptin Hydrobromide Hydrate from Synthetic Mixture by Three Different UV Spectrophotometric Methods","volume":"11","author":"Patel A.","year":"2022","unstructured":"Patel, A.; Jadeja, P.; Mashru, R. Analytical Method Development and Validation for Simultaneous Estimation of Dapagliflozin and Teneligliptin Hydrobromide Hydrate from Synthetic Mixture by Three Different UV Spectrophotometric Methods. World J. Pharm. Res. 2022, 11, 770\u2013783.","journal-title":"World J. Pharm. Res."},{"key":"e_1_3_3_341_1","article-title":"Stability-Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate and Teneligliptin in Tablet Dosage Form","volume":"11","author":"Aakash P.","year":"2023","unstructured":"Aakash, P.; Bhumi, P.; Urvi, R.; Ronak, P.; Jaymin, P. Stability-Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate and Teneligliptin in Tablet Dosage Form. Int. J. Creat. Res. Thought. 2023, 11.","journal-title":"Int. J. Creat. Res. Thought."},{"key":"e_1_3_3_342_1","article-title":"Development and Validation of RP-HPLC Method for Simultaneous Determination of Saroglitazar and DPP4 Inhibitors","volume":"16","author":"Ybvrtjvbaam C. P.","year":"2019","unstructured":"Ybvrtjvbaam, C. P. Development and Validation of RP-HPLC Method for Simultaneous Determination of Saroglitazar and DPP4 Inhibitors. J. Adv. Scholar. Res. All. Ed. 2019, 16.","journal-title":"J. Adv. Scholar. Res. All. Ed."},{"key":"e_1_3_3_343_1","first-page":"2002","article-title":"HPLC Method Development, Validation and Stability Study of Metformin, Voglibose and Teneligliptin in Bulk and Combined Dosage Form","volume":"13","author":"Sakore A.","year":"2021","unstructured":"Sakore, A. HPLC Method Development, Validation and Stability Study of Metformin, Voglibose and Teneligliptin in Bulk and Combined Dosage Form. Intern. J. Pharmaceutic. Res. 2021, 13, 2002\u20132013.","journal-title":"Intern. J. Pharmaceutic. Res."},{"key":"e_1_3_3_344_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2019.05.010"},{"key":"e_1_3_3_345_1","doi-asserted-by":"publisher","DOI":"10.30744\/brjac.2179-3425.AR-47-2022"},{"key":"e_1_3_3_346_1","doi-asserted-by":"publisher","DOI":"10.51248\/.v43i1.2268"},{"key":"e_1_3_3_347_1","doi-asserted-by":"publisher","DOI":"10.37285\/ijpsn.2023.16.2.6"},{"key":"e_1_3_3_348_1","doi-asserted-by":"publisher","DOI":"10.25258\/ijpqa.13.4.25"},{"key":"e_1_3_3_349_1","doi-asserted-by":"publisher","DOI":"10.24941\/ijcr.44281.11.2022"},{"key":"e_1_3_3_350_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S110712"},{"key":"e_1_3_3_351_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2083"},{"key":"e_1_3_3_352_1","article-title":"Simultaneous Quantification and Force Degradation Studies of Remogliflozin, Evogliptin, and Metformin by HILIC Technique","volume":"11","author":"Kadam M. J.","year":"2023","unstructured":"Kadam, M. J.; Singh, R. P.; Charde, M. S. Simultaneous Quantification and Force Degradation Studies of Remogliflozin, Evogliptin, and Metformin by HILIC Technique. Int. J. Creat. Res. Thought. 2023, 11.","journal-title":"Int. J. Creat. Res. Thought."},{"key":"e_1_3_3_353_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.teac.2022.e00157"},{"key":"e_1_3_3_354_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cogsc.2018.12.010"},{"key":"e_1_3_3_355_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2012.12.004"},{"key":"e_1_3_3_356_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.123046"},{"key":"e_1_3_3_357_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70305"},{"key":"e_1_3_3_358_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-025-01501-8"},{"key":"e_1_3_3_359_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16014"},{"key":"e_1_3_3_360_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14810"},{"key":"e_1_3_3_361_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmac055"},{"key":"e_1_3_3_362_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00764-023-00262-z"},{"key":"e_1_3_3_363_1","unstructured":"ANALYTICAL PROCEDURE DEVELOPMENT Q14 [Internet]. 2023 [cited 2026 Jan 30]. Available from: https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Document_Step2_Guideline_2022_0324.pdf."},{"key":"e_1_3_3_364_1","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.70087"},{"key":"e_1_3_3_365_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmae038"},{"key":"e_1_3_3_366_1","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.202300132"},{"key":"e_1_3_3_367_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2025.2610318"},{"key":"e_1_3_3_368_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42250-023-00835-9"},{"key":"e_1_3_3_369_1","doi-asserted-by":"publisher","DOI":"10.1002\/bio.4911"},{"key":"e_1_3_3_370_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10895-025-04514-5"},{"key":"e_1_3_3_371_1","article-title":"Microwave-Derivatized Enhanced Spectrofluorophotometric Characterization of Nateglinide-Loaded Solid Dispersion Adsorbate and Greenness Profile Assessment of Method","author":"Prajapati P.","year":"2025","unstructured":"Prajapati, P.; Mandal, P.; Haque, A.; Ahmad, S.; Shah, S. Microwave-Derivatized Enhanced Spectrofluorophotometric Characterization of Nateglinide-Loaded Solid Dispersion Adsorbate and Greenness Profile Assessment of Method. J. Fluoresc. 2025.","journal-title":"J. Fluoresc."},{"key":"e_1_3_3_372_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmaf051"},{"key":"e_1_3_3_373_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoacint\/qsad108"},{"key":"e_1_3_3_374_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-025-00770-1"},{"key":"e_1_3_3_375_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00746-7"},{"key":"e_1_3_3_376_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42250-023-00819-9"},{"key":"e_1_3_3_377_1","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.70157"},{"key":"e_1_3_3_378_1","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.202300111"},{"key":"e_1_3_3_379_1","doi-asserted-by":"publisher","DOI":"10.1002\/bio.70372"},{"key":"e_1_3_3_380_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.110147"},{"key":"e_1_3_3_381_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-026-10373-9"}],"container-title":["Critical Reviews in Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408347.2026.2667373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:37:45Z","timestamp":1780573065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408347.2026.2667373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":380,"alternative-id":["10.1080\/10408347.2026.2667373"],"URL":"https:\/\/doi.org\/10.1080\/10408347.2026.2667373","relation":{},"ISSN":["1040-8347","1547-6510"],"issn-type":[{"value":"1040-8347","type":"print"},{"value":"1547-6510","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}